| Literature DB >> 34898256 |
Anja Almén1,2, Jónína Guðjónsdóttir3,4, Nils Heimland5, Britta Højgaard6, Hanne Waltenburg6, Anders Widmark5,7.
Abstract
OBJECTIVE: The purpose of this study was to explore the feasibility to determine regional diagnostic reference levels (RDRLs) for paediatric conventional and CT examinations using the European guidelines and to compare RDRLs derived from weight and age groups, respectively.Entities:
Mesh:
Year: 2021 PMID: 34898256 PMCID: PMC8822550 DOI: 10.1259/bjr.20210700
Source DB: PubMed Journal: Br J Radiol ISSN: 0007-1285 Impact factor: 3.039
Summary of the data collected, number of patients, age, weight, number of images or series, and PKA, CTDIvol, and DLP for each patient group
| Examination | # hospitals | Patients | Age, years median | Weight, kg median | # of images/seq. median min[Q1, Q3]max |
|---|---|---|---|---|---|
|
| |||||
| Thorax, supine | 13 (6, 1, 2, 4) | 239 (93, 66, 27, 53) | 1 month (0 – 12 months) | 7 (3 – 11) | 2 1[1,2]4 |
| Thorax erect | 17 (7, 2, 4, 4) | 355 (243, 11, 63, 38) | 10 (6 – 13) | 32 (23 – 48) | 2 1[1,2]4 |
| Abdomen | 18 (6, 2, 3, 7) | 346 (40, 18, 111, 177) | 5 (1–10) | 20 (12 – 31) | 2 1[1,2]4 |
| Pelvis | 15 (7, -, 4, 4) | 235 (162, -, 23, 50) | 5 (2–10) | 20 (13–35) | 1 1[1,2]4 |
| Hip/joints (dysplasia) | 14 (5, -, 3, 6) | 263 (70, -, 57, 136) | 6 months (1–14 months) | 10 (9–12) | 2 1[1,2]4 |
|
| |||||
| CT head | 26 (7, 2, 5, 12) | 1212 (264, 6, 204, 738) | 7 (2.3–11) | 1 sequence (no contrast) | |
| CT thorax, | 8 (2, -, 4, 2) | 121 (19, -, 62, 40) | 4 (2–10) | 18.5 (12–35) | 2 sequences (contrast) |
| CT abdomen | 14 (4, -, 5, 5) | 207 (30, -, 30, 147) | 11 | 38 | 1 sequence |
CTDIvol, volume of CT dose index; DK, Denmark; DLP, dose–length product; IS, Iceland ; NO, Norway ; PKA, kerma–area product;SE, Sweden.
The number of hospitals and patient are also specified for each country; DK, IS, NO and SE.
Figure 1.The age distribution depending on weight, all patients included. The lines indicate the recommended weight-based and age-based groups respectively outlined in the embedded table.[8]
a. Conventional X-ray examinations; patient weight, age, and dose indices for the weight groups, respectively. Each parameter is presented with a median (mean) and first; third quartile. The number (#) of patients in each group is also included. Groups with less than 15 patients were not further considered therefore some cells are left blank. b. CT examinations; patient weight, age, and dose indices for the weight groups, respectively. Each parameter is presented with a median (mean) and first; third quartile. The number (#) of patients in each group is also included. Groups with less than 15 patients were not further considered therefore some cells are left blank
| Weight group | [<5 kg] | [5–<15 kg] | [15–<30 kg] | [30–<50 kg] | [50–<70 kg] |
|---|---|---|---|---|---|
|
| |||||
|
| |||||
| # patients | 104 | 128 | |||
| Weight, kg | 3 (3.1) 2.4; 3.9 | 10 (9.9) 8; 12 | |||
| Age, years | 0 (0.03) 0; 0 | 2 (4.8) 1; 5 | |||
| PKA, Gycm2 | 0.008 (0.014) 0.005; | 0.029 (0.031) 0.015; | |||
|
| |||||
| # patients | 137 | 131 | 84 | ||
| Weight, kg | 22 (21.9) 19; 25 | 36 (37.6) 32; 43 | 57.5 (57.8) 53; 63 | ||
| Age, years | 6 (6.3) 5; 7 | 11 (10.9) 9.5; 13 | 14 (13.8) 13; 15 | ||
| PKA, Gycm2 | 0.018 (0.021) 0.009; | 0.028 (0.038) 0.013; | 0.061 (0.088) 0.034; | ||
|
| |||||
| # patients | 96 | 134 | 75 | 28 | |
| Weight, kg | 10 (10) 8; 12 | 20.9 (21) 17.4; 25 | 35 (36.8) 31.3; 42 | 52 54.8 50; 58.5 | |
| Age, years | 0.7 (1.0) 0.2; 1.1 | 6.0 (5.5) 4.0; 7.8 | 10.0 (10.7) 9.3; 12 | 13 (12.8) 11; 14 | |
| PKA, Gycm2 | 0.039 (0.058) 0.025; | 0.140 (0.204) 0.050; | 0.232 (0.395) 0.092; | 0.566 (0.942) 0.208; | |
|
| |||||
| # patients | 87 | 104 | 49 | 42 | |
| Weight, kg | 11 (10.7) 9; 13 | 20 (20.4) 16; 24 | 39 (38.1) 32; 43 | 54 (55.8) 51; 60 | |
| Age, years | 0.9 (1.2) 0.2; 1.9 | 5 (5.6) 4; 7 | 11 (10.9) 9; 13 | 14 (13.4) 12; 15 | |
| PKA, Gycm2 | 0.023 (0.034) 0.012; | 0.060 (0.104) 0.034; | 0.185 (0.240) 0.083; | 0.425 (0.501) 0.237; | |
|
| |||||
| # patients | 234 | 23 | |||
| Weight, kg | 10.0 (10.1) 8.9; 12.0 | 15.5 (16.2) 15; 17.5 | |||
| Age, years | 1 (1.2) 0.9; 2.0 | 2.9 (2.7) 2.0; 3.4 | |||
| PKA, Gycm2 | 0.022 (0.034) 0.011; | 0.047 (0.063) 0.023; | |||
|
| |||||
|
| |||||
| # patients | 34 | 38 | 24 | 17 | |
| Weight, kg | 10.4 (10.4) 9; 12.4 | 18.8 (20.7) 17; 24.8 | 36 (37.8) 34; 40.2 | 55 (57.2) 51; 63 | |
| Age, years | 1.4 (1.5) 1.0; 2.1 | 4.5 (5.6) 4; 7.8 | 10.5 (10.3) 8.8; 11.5 | 13.0 (13.0) 13; 14 | |
| CTDI, mGy | 1.0 (1.9) 0.75; | 1.3 (1.5) 1.1; | 1.7 (2.0) 1.6; | 2.6 (3.1) 2.1; | |
| DLP, mGycm | 18.8 (35.0) 14.4; | 30.9 (38.6) 24.7; | 42.4 (54.5) 39.3; | 93.0 (103.1) 62.9; | |
|
| |||||
| # patients | 60 | 82 | 57 | ||
| Weight, kg | 23.8 (23.5) 20.8; 27.0 | 40 (39.8) 34; 45 | 58 (58.7) 53; 64 | ||
| Age, years | 7.0 (7.2) 10; 13 | 11.0 (11.1) 10; 13 | 14 (13.3) 13; 14 | ||
| CTDI, mGy | 1.8 (2.1) 1.5; | 2.7 (2.8) 2.0; | 4.2 (4.3) 3.1; | ||
| DLP, mGycm | 70.5 (78.7) 52.8; | 115.5 (120.8) 80.5; | 189.2 (201.1) 153.8; | ||
|
|
|
|
|
| |
|
| |||||
| # patients | 101 | 102 | 304 | 704 | |
| Age, years | 0.1 (0.1) 0.1; 0.2 | 0.5 (0.5) 0.3; 0.8 | 3.6 (3.3) 1.8; 4.3 | 11.2 (10.7) 8.2; 13.2 | |
| CTDI, mGy | 22.8 (22.8) 20.0; | 22.8 (23.7) 20.0; | 25.9 (27.4) 22.8; | 31.8 (33.7) 26.0; | |
| DLP, mGycm | 361 (365) 318; | 363 (365) 306; | 433 (454) 382; | 555 (589) 469; |
CTDI, CT dose index; DLP, dose–length product; PKA, kerma–area product.
Proposed RDRLs derived in this study, EDRLs, and NDRLs from France and Ireland concerning conventional X-ray examinations
| RDRL | EDRL | NDRL, France | NDRL, Ireland | |
|---|---|---|---|---|
|
|
|
|
|
|
| <5 kg | 0.013 | 0.015 | 0.009 | |
| [5–<15 kg] | 0.040 | 0.022 | 0.015 | 0.017 |
|
| ||||
| [15–<30 kg] | 0.028 | 0.050 | 0.035 | 0.022 |
| [30–<50 kg] | 0.050 | 0.070 | 0.050 | |
| [50–<70 kg] | 0.097 | 0.087 | 0.070 | |
|
| ||||
| [5–<15 kg] | 0.073 | 0.150 | 0.060 | 0.063 |
| [15–<30 kg] | 0.237 | 0.250 | 0.220 | 0.100 |
| [30–<50 kg] | 0.534 | 0.475 | 0.286 | |
| [50–<70 kg] | 1.54 | 0.700 | 0.457 | |
|
| ||||
| [5–<15 kg] | 0.041 | 0.039 | ||
| [15–<30 kg] | 0.130 | 0.180 | 0.110 | 0.111 |
| [30–<50 kg] | 0.330 | 0.310 | 0.580 | 0.412 |
| [50–<70 kg] | 0.646 | 0.800 | ||
|
| ||||
| [5–<15 kg] | 0.048 | |||
| [15–<30 kg] | 0.088 |
EDRL, European diagnostic reference level; NDRL, national diagnostic reference level; RDRL, regional diagnostic reference level.
Proposed RDRLs derived in this study, EDRLs, and NDRLs from France, Ireland and the UK for CT examinations
| RDRL | EDRL | NDRL, France | NDRL, Ireland | NDRL, UK | |
|---|---|---|---|---|---|
|
| |||||
|
| |||||
| [0–< 3 months] | 403 | 300 | 239 | 350 | |
| [3 months–< 1 year] | 398 | 385 | 376 | 350 | |
| [1–< 6 years] | 516 | 505 | 450 | 536 | 650 |
| [>=6 years] | 679 | 650 | 530 | 742 | 860 |
|
| |||||
| [5–<15 kg] | 25 | 50 | 29/20a | 81 | |
| [15–<30 kg] | 41 | 70 | 43/36a | 99 | |
| [30–<50 kg] | 65 | 115 | 166 | ||
| [50–<70 kg] | 103 | 200 | 131 | ||
|
| |||||
| [15–<30 kg] | 92 | 150 | 92 | 168 | |
| [30–<50 kg] | 150 | 210 | 170 | 210 | |
| [50–<70 kg] | 247 | 480 | 397 | ||
|
| |||||
|
| |||||
|
| 28 | 24 | 25 | ||
|
| 27 | 28 | 25 | ||
|
| 31 | 40 | 22 | 40 | |
|
| 39 | 50 | 26 | 60 | |
|
| |||||
| [5–<15 kg] | 1.2 | 1.8 | 1.5/1.1a | ||
| [15–<30 kg] | 1.6 | 2.7 | 1.5/1.4a | ||
| [30–<50 kg] | 2.4 | 3.7 | |||
| [50–<70 kg] | 3.0 | 5.4 | |||
|
| |||||
| [15–<30 kg] | 2.6 | 5.4 | 2.3 | ||
| [30–<50 kg] | 3.4 | 7.3 | 3.6 | ||
| [50–<70 kg] | 5.0 | 13 |
CTDI, CT dose index; DLP, dose–length product; EDRL, European diagnostic reference level; NDRL, national diagnostic reference level; RDRL, regional diagnostic reference level.
France, CT chest: with contrast (mediastinum/lung).
UK, trauma.